AR061240A1 - Compuestos de de 4-isoquinolin-fenol,composiciones farmaceuticas que los contienen y su uso como agentes antineoplasicos y/o antivirales. - Google Patents
Compuestos de de 4-isoquinolin-fenol,composiciones farmaceuticas que los contienen y su uso como agentes antineoplasicos y/o antivirales.Info
- Publication number
- AR061240A1 AR061240A1 ARP070102429A ARP070102429A AR061240A1 AR 061240 A1 AR061240 A1 AR 061240A1 AR P070102429 A ARP070102429 A AR P070102429A AR P070102429 A ARP070102429 A AR P070102429A AR 061240 A1 AR061240 A1 AR 061240A1
- Authority
- AR
- Argentina
- Prior art keywords
- isoquinolin
- phenol
- antineoplasic
- compounds
- contain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Compuesto de 4-[5-(2-amino-etansulfonil)-isoquinolin-7-iI]-fenol, o una sal del mismo farmacéuticamente aceptable o un hidrato del compuesto o la sal del mismo. Uso para la manufactura de un medicamento util como inhibidor de AKt, antineoplásico y/o antiviral, para tratar mieloma multiple, cáncer de pulmon de células no pequenas, glioblastoma, neuroblastoma, melanoma o neoplasmas de la prostata, mama, ovarios, estomago primario, tipo intestinal, endometrio tiroides, páncreas, pulmon o vejiga, hepatitis C, rubéola, virus de inmunodeficiencia humana (VIH), hepatitis V, o citomegalovirus humano (HCMV). Composicion farmacéutica que lo comprende. Forma cristalina del semi-hidrato monoclorhidrato correspondiente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80526006P | 2006-06-20 | 2006-06-20 | |
| US88576507P | 2007-01-19 | 2007-01-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061240A1 true AR061240A1 (es) | 2008-08-13 |
Family
ID=38834248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102429A AR061240A1 (es) | 2006-06-20 | 2007-06-06 | Compuestos de de 4-isoquinolin-fenol,composiciones farmaceuticas que los contienen y su uso como agentes antineoplasicos y/o antivirales. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7998977B2 (es) |
| EP (1) | EP2035385B1 (es) |
| JP (1) | JP2009541335A (es) |
| KR (1) | KR101067551B1 (es) |
| AR (1) | AR061240A1 (es) |
| AT (1) | ATE455102T1 (es) |
| AU (1) | AU2007261120A1 (es) |
| BR (1) | BRPI0713136A2 (es) |
| CA (1) | CA2652612A1 (es) |
| CL (1) | CL2007001752A1 (es) |
| DE (1) | DE602007004333D1 (es) |
| DK (1) | DK2035385T3 (es) |
| DO (1) | DOP2008000053A (es) |
| EA (1) | EA015712B1 (es) |
| EC (1) | ECSP088992A (es) |
| ES (1) | ES2336630T3 (es) |
| HR (1) | HRP20100147T1 (es) |
| IL (1) | IL195005A0 (es) |
| MA (1) | MA30757B1 (es) |
| MX (1) | MX2008015904A (es) |
| NO (1) | NO20090289L (es) |
| PE (1) | PE20080338A1 (es) |
| PL (1) | PL2035385T3 (es) |
| PT (1) | PT2035385E (es) |
| SI (1) | SI2035385T1 (es) |
| TN (1) | TNSN08529A1 (es) |
| TW (1) | TW200812970A (es) |
| WO (1) | WO2007149730A2 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5856843B2 (ja) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ，インコーポレイテッド | ジケトピペラジンを用いた医薬組成物 |
| CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
| ES2795803T3 (es) | 2011-10-10 | 2020-11-24 | Ampio Pharmaceuticals Inc | Tratamiento de artropatía degenerativa |
| SG10201608087WA (en) | 2011-10-10 | 2016-11-29 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| AU2012328605B9 (en) | 2011-10-28 | 2017-08-03 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| EA201500943A1 (ru) | 2013-03-15 | 2016-08-31 | Ампио Фармасьютикалс, Инк. | Составы для мобилизации, хоуминга, размножения и дифференцировки стволовых клеток и способы применения составов |
| US9974774B2 (en) | 2013-07-26 | 2018-05-22 | Race Oncology Ltd. | Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof |
| US9956217B2 (en) | 2014-08-18 | 2018-05-01 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
| WO2016201605A1 (zh) * | 2015-06-15 | 2016-12-22 | 廖勇 | 一种治疗乙型肝炎病毒的靶点 |
| EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | USE OF LOW MOLECULAR WEIGHT HUMAN SERUM ALBUMIN FRACTIONS FOR TREATING DISEASES |
| US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
| WO2022017448A1 (zh) * | 2020-07-22 | 2022-01-27 | 南京正大天晴制药有限公司 | 一种二氢吡啶并[2,3-d]嘧啶酮衍生物的盐及晶型 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136458A0 (en) | 2000-05-30 | 2001-06-14 | Peptor Ltd | Protein kinase inhibitors |
| CA2518180A1 (en) * | 2003-03-28 | 2004-11-04 | Eli Lilly And Company | Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| GB0317315D0 (en) | 2003-07-24 | 2003-08-27 | Astex Technology Ltd | Pharmaceutical compounds |
| WO2005054202A1 (en) | 2003-11-25 | 2005-06-16 | Eli Lilly And Company | 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b) |
-
2007
- 2007-06-06 AR ARP070102429A patent/AR061240A1/es unknown
- 2007-06-12 SI SI200730212T patent/SI2035385T1/sl unknown
- 2007-06-12 MX MX2008015904A patent/MX2008015904A/es active IP Right Grant
- 2007-06-12 KR KR1020087030916A patent/KR101067551B1/ko not_active IP Right Cessation
- 2007-06-12 DE DE602007004333T patent/DE602007004333D1/de active Active
- 2007-06-12 US US12/300,358 patent/US7998977B2/en not_active Expired - Fee Related
- 2007-06-12 DK DK07798410.2T patent/DK2035385T3/da active
- 2007-06-12 BR BRPI0713136-4A patent/BRPI0713136A2/pt not_active IP Right Cessation
- 2007-06-12 JP JP2009516633A patent/JP2009541335A/ja not_active Ceased
- 2007-06-12 EP EP07798410A patent/EP2035385B1/en active Active
- 2007-06-12 AU AU2007261120A patent/AU2007261120A1/en not_active Abandoned
- 2007-06-12 PT PT07798410T patent/PT2035385E/pt unknown
- 2007-06-12 PL PL07798410T patent/PL2035385T3/pl unknown
- 2007-06-12 EA EA200970041A patent/EA015712B1/ru not_active IP Right Cessation
- 2007-06-12 WO PCT/US2007/070945 patent/WO2007149730A2/en active Application Filing
- 2007-06-12 CA CA002652612A patent/CA2652612A1/en not_active Abandoned
- 2007-06-12 ES ES07798410T patent/ES2336630T3/es active Active
- 2007-06-12 AT AT07798410T patent/ATE455102T1/de active
- 2007-06-15 CL CL2007001752A patent/CL2007001752A1/es unknown
- 2007-06-18 PE PE2007000768A patent/PE20080338A1/es not_active Application Discontinuation
- 2007-06-20 TW TW096122142A patent/TW200812970A/zh unknown
-
2008
- 2008-10-24 DO DO2008000053A patent/DOP2008000053A/es unknown
- 2008-10-30 IL IL195005A patent/IL195005A0/en unknown
- 2008-12-18 EC EC2008008992A patent/ECSP088992A/es unknown
- 2008-12-19 TN TNP2008000529A patent/TNSN08529A1/en unknown
-
2009
- 2009-01-19 MA MA31573A patent/MA30757B1/fr unknown
- 2009-01-19 NO NO20090289A patent/NO20090289L/no not_active Application Discontinuation
-
2010
- 2010-03-15 HR HR20100147T patent/HRP20100147T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA30757B1 (fr) | 2009-10-01 |
| CA2652612A1 (en) | 2007-12-27 |
| KR20090015978A (ko) | 2009-02-12 |
| JP2009541335A (ja) | 2009-11-26 |
| CL2007001752A1 (es) | 2008-01-18 |
| AU2007261120A1 (en) | 2007-12-27 |
| HRP20100147T1 (hr) | 2010-04-30 |
| ATE455102T1 (de) | 2010-01-15 |
| EA015712B1 (ru) | 2011-10-31 |
| IL195005A0 (en) | 2009-08-03 |
| PE20080338A1 (es) | 2008-04-25 |
| WO2007149730A2 (en) | 2007-12-27 |
| EP2035385B1 (en) | 2010-01-13 |
| KR101067551B1 (ko) | 2011-09-27 |
| TNSN08529A1 (en) | 2010-04-14 |
| PL2035385T3 (pl) | 2010-06-30 |
| DOP2008000053A (es) | 2009-01-15 |
| ES2336630T3 (es) | 2010-04-14 |
| TW200812970A (en) | 2008-03-16 |
| ECSP088992A (es) | 2009-01-30 |
| EP2035385A2 (en) | 2009-03-18 |
| PT2035385E (pt) | 2010-03-01 |
| NO20090289L (no) | 2009-01-19 |
| SI2035385T1 (sl) | 2010-05-31 |
| DK2035385T3 (da) | 2010-03-22 |
| US20090221633A1 (en) | 2009-09-03 |
| EA200970041A1 (ru) | 2009-06-30 |
| US7998977B2 (en) | 2011-08-16 |
| MX2008015904A (es) | 2009-01-12 |
| WO2007149730A3 (en) | 2008-04-24 |
| DE602007004333D1 (de) | 2010-03-04 |
| BRPI0713136A2 (pt) | 2012-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR061240A1 (es) | Compuestos de de 4-isoquinolin-fenol,composiciones farmaceuticas que los contienen y su uso como agentes antineoplasicos y/o antivirales. | |
| HRP20191617T1 (hr) | Kombinacija koja sadrži inhibitor mek i inhibitor b-raf | |
| AR062745A1 (es) | 2-[4-(7-etil-5h-pirrolo[2,3-b]pirazin-6-il)-fenil]-propan-2-ol como inhibidor de quinasa | |
| TN2018000087A1 (en) | New pyrrolo[2,3-d]pyrimidine derivatives as dual dyrk1/clk1 inhibitors | |
| GEP20125487B (en) | Organic compounds and their use | |
| PT2242743E (pt) | Derivados de aminopirazol | |
| SV2018005655A (es) | "derivados de 8-[6-[3-(amino)propoxi]-3-piridil]1-isopropilimidazo[4,5-c]quinolin-2-ona como moduladores selectivos de la cinasa de la ataxia telangiectasia mutada (atm) para el tratamiento del cancer" | |
| MY157495A (en) | 6-,7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same | |
| CL2007002316A1 (es) | Compuestos derivados de pirimidina, inhibidores de pi3k; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades proliferativas como cancer. | |
| MX2015012432A (es) | Inhibidores piridinicos de la cinasa cdk9. | |
| UY31918A (es) | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento | |
| UA115320C2 (uk) | Інгібітори кінази | |
| AR060631A1 (es) | Derivados de pirimidina y su uso como inhibidores de fosfatidilnositol 3-quinasa (pi3k) | |
| ECSP12012042A (es) | Derivados de pirazol como inhibidores de jak | |
| NI201000003A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas. | |
| ATE483707T1 (de) | 2-cyclopropylthiazolderivate | |
| CO6382131A2 (es) | Derivados de tieno [3,2-c]piridina como inhibidores de quinasas para el uso en el tratamiento del cáncer | |
| ECSP109856A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842 | |
| EA201000614A1 (ru) | Производные пурина как лиганды аденозинового рецептора а | |
| CY1117792T1 (el) | Ανταγωνιστες toy trpv4 | |
| PA8843901A1 (es) | INHIBIDORES DE PIRIMIDINONA DE PI3K( ALFA) Y m TOR | |
| CL2009000241A1 (es) | Compuestos derivados de 5-(2-morfolin-4-il-7h-pirrolo[2,3-d]pirimidin-4-il)pirimidin-2-ilamina; proceso de preparacion; composicion farmaceutica; y uso de los compuestos para tratar o prevenir una enfermedad proliferativa tal como el cancer. | |
| CL2019001694A1 (es) | Compuestos de pirazolopirimidina y métodos de uso de los mismos. | |
| BR112012023660B8 (pt) | usos de uma quantidade terapeuticamente eficaz de um composto, ou de um sal, solvato, hidrato ou pró-fármaco farmaceuticamente aceitável do mesmo para o tratamento de câncer | |
| CR20140031A (es) | Derivados de piridin-2(1h)-ona como inhibidores de jak |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |